{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T10:46:50Z","timestamp":1707734810242},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,9]]},"DOI":"10.7759\/cureus.18620","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T17:23:13Z","timestamp":1633886593000},"source":"Crossref","is-referenced-by-count":2,"title":["Extra-Articular Manifestations in Reactive Arthritis due to COVID-19"],"prefix":"10.7759","author":[{"given":"Juan Camilo","family":"Santacruz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Londo\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Arzuaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta Juliana","family":"Mantilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3109\/rhe1.1969.15.issue-1-4.32","article-title":"Arthritis associated with Yersinia enterocolitica infection","volume":"15","author":"Ahvonen P","year":"1969","unstructured":"Ahvonen P, Sievers K, Aho K. Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatol Scand. 1969, 15:232-53. 10.3109\/rhe1.1969.15.issue-1-4.32","journal-title":"Acta Rheumatol Scand"},{"key":"ref2","article-title":"On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6, 1999","volume":"27","author":"Braun J","year":"2000","unstructured":"Braun J, Kingsley G, van der Heijde D, Sieper J. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6, 1999. J Rheumatol. 2000, 27:2185-92.","journal-title":"J Rheumatol"},{"key":"ref3","article-title":"Reactive arthritis--the appropriate name","volume":"10","author":"Keynan Y","year":"2008","unstructured":"Keynan Y, Rimar D. Reactive arthritis--the appropriate name. Isr Med Assoc J. 2008, 10:256-8.","journal-title":"Isr Med Assoc J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001350","article-title":"Reactive arthritis after COVID-19 infection","volume":"6","author":"Ono K","year":"2020","unstructured":"Ono K, Kishimoto M, Shimasaki T, et al.. Reactive arthritis after COVID-19 infection. RMD Open. 2020, 6:2-5. 10.1136\/rmdopen-2020-001350","journal-title":"RMD Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.005","article-title":"Diagnosis and classification of reactive arthritis","volume":"13","author":"Selmi C","year":"2014","unstructured":"Selmi C, Gershwin ME. Diagnosis and classification of reactive arthritis. Autoimmun Rev. 2014, 13:546-9. 10.1016\/j.autrev.2014.01.005","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/01.JAA.0000558320.47868.2f","article-title":"An overview of reactive arthritis","volume":"32","author":"Pennisi M","year":"2019","unstructured":"Pennisi M, Perdue J, Roulston T, Nicholas J, Schmidt E, Rolfs J. An overview of reactive arthritis. JAAPA. 2019, 32:25-8. 10.1097\/01.JAA.0000558320.47868.2f","journal-title":"JAAPA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2009.03.010","article-title":"Reactive arthritis: clinical aspects and medical management","volume":"35","author":"Carter JD","year":"2009","unstructured":"Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am. 2009, 35:21-44. 10.1016\/j.rdc.2009.03.010","journal-title":"Rheum Dis Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.010710","article-title":"Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study","volume":"63","author":"Kvien TK","year":"2004","unstructured":"Kvien TK, Gaston JS, Bardin T, et al.. Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study. Ann Rheum Dis. 2004, 63:1113-9. 10.1136\/ard.2003.010710","journal-title":"Ann Rheum Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2015.69.42-45","article-title":"Modes of presentation of reactive arthritis based on the affected joints","volume":"69","author":"Lahu A","year":"2015","unstructured":"Lahu A, Backa T, Ismaili J, Lahu V, Saiti V. Modes of presentation of reactive arthritis based on the affected joints. Med Arch. 2015, 69:42-5. 10.5455\/medarh.2015.69.42-45","journal-title":"Med Arch"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780240612","article-title":"Reiter's syndrome. Evaluation of preliminary criteria for definite disease","volume":"24","author":"Willkens RF","year":"1981","unstructured":"Willkens RF, Arnett FC, Bitter T, et al.. Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum. 1981, 24:844-9. 10.1002\/art.1780240612","journal-title":"Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2017.01.013","article-title":"A bicentre retrospective study of features and outcomes of patients with reactive arthritis","volume":"85","author":"Courcoul A","year":"2018","unstructured":"Courcoul A, Brinster A, Decullier E, et al.. A bicentre retrospective study of features and outcomes of patients with reactive arthritis. Joint Bone Spine. 2018, 85:201-5. 10.1016\/j.jbspin.2017.01.013","journal-title":"Joint Bone Spine"},{"key":"ref12","article-title":"[Ophthalmological aspects of Reiter's disease]","volume":"106","author":"Kovalev IuN","year":"1990","unstructured":"Kovalev IuN, Il'in II. [Ophthalmological aspects of Reiter's disease]. Vestn Oftalmol. 1990, 106:65-9.","journal-title":"Vestn Oftalmol"},{"key":"ref13","article-title":"","author":"Espinoza LR","year":"2019","unstructured":"Espinoza LR, ed. Infections and the Rheumatic Diseases [Internet]. Springer International Publishing, Cham; 2019. http:\/\/link.springer.com\/10.1007\/978-3-030-23311-2."},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1097\/00124743-200006000-00003","article-title":"A clinical profile of reactive arthritis in a Peruvian series: a pilot study","volume":"6","author":"Angulo JM","year":"2000","unstructured":"Angulo JM, Castro F, Quispe E, Espinoza LR. A clinical profile of reactive arthritis in a Peruvian series: a pilot study. J Clin Rheumatol. 2000, 6:128-35.","journal-title":"J Clin Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218520","article-title":"Transient monoarthritis and psoriatic skin lesions following COVID-19 [Online ahead of print]","author":"De Stefano L","year":"2020","unstructured":"De Stefano L, Rossi S, Montecucco C, Bugatti S. Transient monoarthritis and psoriatic skin lesions following COVID-19 [Online ahead of print]. Ann Rheum Dis. 2020, 10.1136\/annrheumdis-2020-218520","journal-title":"Ann Rheum Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01441","article-title":"Immune response, inflammation, and the clinical spectrum of COVID-19","volume":"11","author":"Garc\u00eda LF","year":"2020","unstructured":"Garc\u00eda LF. Immune response, inflammation, and the clinical spectrum of COVID-19. Front Immunol. 2020, 11:1441. 10.3389\/fimmu.2020.01441","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0328-z","article-title":"COVID-19: a case for inhibiting IL-17?","volume":"20","author":"Pacha O","year":"2020","unstructured":"Pacha O, Sallman MA, Evans SE. COVID-19: a case for inhibiting IL-17?. Nat Rev Immunol. 2020, 20:345-6. 10.1038\/s41577-020-0328-z","journal-title":"Nat Rev Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17292-4","article-title":"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia","volume":"11","author":"De Biasi S","year":"2020","unstructured":"De Biasi S, Meschiari M, Gibellini L, et al.. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020, 11:3434. 10.1038\/s41467-020-17292-4","journal-title":"Nat Commun"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/art.30272","article-title":"Safety and efficacy of anti-tumor necrosis factor \u03b1 therapy in ten patients with recent-onset refractory reactive arthritis","volume":"63","author":"Meyer A","year":"2011","unstructured":"Meyer A, Chatelus E, Wendling D, et al.. Safety and efficacy of anti-tumor necrosis factor \u03b1 therapy in ten patients with recent-onset refractory reactive arthritis. Arthritis Rheum. 2011, 63:1274-80. 10.1002\/art.30272","journal-title":"Arthritis Rheum"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/72521-extra-articular-manifestations-in-reactive-arthritis-due-to-covid-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:16Z","timestamp":1707507076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/72521-extra-articular-manifestations-in-reactive-arthritis-due-to-covid-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.18620","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,9]]}}}